Abstract:Altered metabolism is a hallmark of cancer and glycolysis is one of the important factors promoting tumor development. There is however still a lack of molecular characterization glycolysis and comprehensive studies related to tumor glycolysis in the pan-cancer landscape. Here, we applied a gene expression signature to quantify glycolysis in 9229 tumors across 25 cancer types and 7875 human lung cancer single cells and verified the robustness of signature using defined glycolysis samples from previous studies. We classified tumors and cells into glycolysis score-high and -low groups, demonstrated their prognostic associations, and identified genome and transcriptome molecular features associated with glycolysis activity. We observed that glycolysis score-high tumors were associated with worse prognosis across cancer types. High glycolysis tumors exhibited specific driver genes altered by copy number aberrations (CNAs) in most cancer types. Tricarboxylic acid (TCA) cycle, DNA replication, tumor proliferation and other cancer hallmarks were more active in glycolysis-high tumors. Glycolysis signature was strongly correlated with hypoxia signature in all 25 cancer tissues (r > 0.7) and cancer single cells (r > 0.8). In addition, HSPA8 and P4HA1 were screened out as the potential modulating factors to glycolysis as their expression were highly correlated with glycolysis score and glycolysis genes, which enables future efforts for therapeutic options to block the glycolysis and control tumor progression. Our study provides a comprehensive molecular-level understanding of glycolysis with a large sample data and demonstrates the hypoxia pressure, growth signals, oncogene mutation and other potential signals could activate glycolysis, thereby to regulate cell cycle, energy material synthesis, cell proliferation and cancer progression.

Regulation of gene expression by glycolytic and gluconeogenic enzymes

Regulation of cancer metabolism by O-GlcNAcylation

Dysregulation of glucose metabolism in tumorigenesis and tumor progression

Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy

Regulation of Chromatin and Gene Expression by Metabolic Enzymes and Metabolites

m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

The Epigenetic Basis of the Warburg Effect

Advancements in the study of glucose metabolism in relation to tumor progression and treatment

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

Regulatory function of glycolysis-related lncRNAs in tumor progression: Mechanism, facts, and perspectives

Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data

Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer

Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer.

Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target

LncRNAs: The Regulator of Glucose and Lipid Metabolism in Tumor Cells

Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment

Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways

Proteins Moonlighting in Tumor Metabolism and Epigenetics

Regulatory Role of Cancer Microenvironment in Cancer Metabolism

Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key